Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06196190 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Prognostic Value of Conization and Negative HPV After Conization in AIS and Early Stage Cervical Cancer

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated January 9, 2024 (before its estimated August 1, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
In women with cervical cancer -Squamous cell carcinoma, Adeno carcinoma, Adeno-squamous carcinoma or AIS we want to examine prospectively: 1. Examine if negative HR-HPV after conization to the HR-HPV the women had before conization has a high prognostic value for no residual tumor in the final pathology. 2. To examine if conization in women with cervical tumor up to Stage I B 2 (FIGO 2018) is corelated with better prognosis.
Trial Details
NCT Number NCT06196190
Lead Sponsor Rambam Health Care Campus
Conditions
(from sponsor)		 Cervix Cancer, HPV-Related Malignancy
Related terms Uterine Cervical Neoplasms
Enrollment 200 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov